Inotodiol ameliorates the progression of osteoarthritis: An in vitro and in vivo study
Drug Research · 01.11.2023 · 73 (09) · 506-512
DOI: 10.1055/a-2176-4098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 01.11.2023. Verfasst von Wanfeng Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Shaoxing University of Arts and Sciences. Hauptthemen laut MEDLINE: Lanosterol, Osteoarthritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Osteoarthritis is a common chronic degenerative disease, of which the essence is the degenerative changes of bone and joint cartilage, involving damage in multiple structures such as bone, synovium and joints. In the mechanism of arthritis inflammation is closely related, and therefore the exploration to inhibit inflammatory mediators is crucial for the clinical prevention and treatment of osteoarthritis. Inotodiol is a lanostane triterpenoid isolated from Inonotus obliquus, which had been extensively reported to be an anti-inflammatory agent, but its effect on arthritis remains unknown. In this study, we firstly demonstrated that inotodiol significantly reduced IL-1β-induced chondrocyte injury and inhibited the release of inflammatory factors. At the same time, experiments in vivo showed that inotodiol could effectively improve the symptoms of joint injury in mice and reduce the area of cartilage destruction, indicating that inotodiol may be a potential therapeutic drug for osteoarthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Affiliated Hospital of Shaoxing University of Arts and Sciences.
- The first People's Hospital of Guannan County, Jiangsu, China.
- Department of Orthopaedics, 72nd Group Army Hospital, Huzhou University, Huzhou, Zhejiang, China.
Zitieren
APA
Qian, W., Ji, R., Ye, Q., Hu, W., Zhou, L., Pan, H., & Li, X. (2023). Inotodiol ameliorates the progression of osteoarthritis: An in vitro and in vivo study. Drug Research, 73(09), 506-512. https://doi.org/10.1055/a-2176-4098
Vancouver
Qian W, Ji R, Ye Q, Hu W, Zhou L, Pan H, et al. Inotodiol ameliorates the progression of osteoarthritis: An in vitro and in vivo study. Drug Research. 2023;73(09):506-512. doi:10.1055/a-2176-4098
BibTeX
@article{Qian2023,
author = {Qian, Wanfeng and Ji, Ruheng and Ye, Qiujie and Hu, Wenjun and Zhou, Linying and Pan, Hongwu and Li, Xiaoming},
title = {Inotodiol ameliorates the progression of osteoarthritis: An in vitro and in vivo study},
journal = {Drug Research},
year = {2023},
volume = {73},
number = {09},
pages = {506--512},
doi = {10.1055/a-2176-4098}
}
EUVIMED